Page 255

identified among prisoners and new cases of TB have decreased 83 percent since their peak in 1991. Liaison from the Board on International Health

BARRY R. BLOOM, Ph.D., dean of the Harvard School of Public Health and professor of immunology and infectious disease. Barry R. Bloom received his B.A. and an honorary Sc.D. from Amherst College and his Ph.D. from the Rockefeller University. Dr. Bloom is an immunologist and microbiologist engaged in research on infectious diseases and vaccines. Before going to Harvard, Dr. Bloom was an investigator of the Howard Hughes Medical Institute and the Weinstock Professor of Microbiology and Immunology at the Albert Einstein College of Medicine. He is a member of the Scientific Advisory Board of the National Center for Infectious Diseases at the Centers for Disease Control and Prevention. He chairs the Board of Trustees of the newly established International Vaccine Institute and is cochair of the Board on Global Health of the Institute of Medicine. He is chairman of the Vaccine Advisory Committee of UNAIDS and a member of the U.S. AIDS Vaccine Research Committee. In 1991, he received the first Bristol-Myers Squibb Award for Distinguished Research in Infectious Diseases and in 1998 received the Novartis Prize in Immunology. Dr. Bloom is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the Institute of Medicine. Liaison to the Board on Health Promotion and Disease Prevention

ROBERT FULLILOVE, Ed.D., Columbia University School of Public Health. Robert Fullilove received his Ed.D. from Columbia University. He is currently the associate dean for community and minority affairs at Columbia University's School of Public Health. He is also an associate professor of clinical public health and the codirector of the Community Research Group at the New York State Psychiatric Institute. His research includes HIV disease among people of color, crack cocaine use and sexually transmitted disease in the AIDS era, and trauma-related disorders and their impact on sexual risk taking. He is a member of the Board of Health Promotion and Disease Prevention of the Institute of Medicine and has served as a member/nominee to the Centers for Disease Control and Prevention's Advisory Committee on HIV and STD Prevention.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement